IFOSFAMIDE FOR INJECTION

IFOSFAMIDE FOR INJECTION was reported 21470 times

IFOSFAMIDE FOR INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 T-CELL LYMPHOMA REFRACTORY 25 0.7143
1 PERIPHERAL BLOOD STEM CELL APHERESIS 10 0.6250
2 DESMOPLASTIC SMALL ROUND CELL TUMOUR 41 0.4713
3 RHABDOMYOSARCOMA RECURRENT 20 0.4651
4 RHABDOID TUMOUR 16 0.3077
5 OSTEOSARCOMA RECURRENT 18 0.3000
6 HAEMATOPOIETIC STEM CELL MOBILISATION 19 0.2969
7 MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA 13 0.2549
8 PRIMITIVE NEUROECTODERMAL TUMOUR 11 0.2037
9 LEUKOERYTHROBLASTOSIS 19 0.1900
10 AMELOBLASTOMA 10 0.1887
11 BLOOD STEM CELL TRANSPLANT FAILURE 39 0.1814
12 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 16 0.1798
13 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 163 0.1721
14 OVARIAN FAILURE 92 0.1720
15 B-CELL LYMPHOMA REFRACTORY 14 0.1573
16 SYNOVIAL SARCOMA 14 0.1474
17 PLEUROPARENCHYMAL FIBROELASTOSIS 15 0.1442
18 ENCEPHALITIS ENTEROVIRAL 16 0.1416
19 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 294 0.1332
20 MALIGNANT TRANSFORMATION 57 0.1269
21 FOLLICULAR LYMPHOMA RECURRENT 10 0.1250
22 OSTEOSARCOMA 48 0.1247
23 NEPHROBLASTOMA 14 0.1102
24 ADENOVIRUS REACTIVATION 15 0.1042
25 CONGENITAL APLASIA 31 0.0997
26 OSTEOSARCOMA METASTATIC 9 0.0947
27 MENINGITIS TUBERCULOUS 51 0.0912
28 SALIVARY GLAND CANCER 44 0.0892
29 B-CELL LYMPHOMA RECURRENT 46 0.0847
30 NEUROBLASTOMA RECURRENT 17 0.0837
31 BONE SARCOMA 16 0.0825
32 RHABDOMYOSARCOMA 15 0.0798
33 DELAYED PUBERTY 20 0.0787
34 FANCONI SYNDROME 109 0.0770
35 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 25 0.0762
36 MYELOID LEUKAEMIA 36 0.0719
37 ANAL INFLAMMATION 42 0.0657
38 ADENOVIRAL HEPATITIS 15 0.0638
39 LYMPHOMA TRANSFORMATION 22 0.0611
40 REFRACTORY CANCER 13 0.0610
41 PNEUMONIA ADENOVIRAL 12 0.0606
42 FOLLICULAR LYMPHOMA 53 0.0602
43 ASPERGILLUS INFECTION 395 0.0601
44 AZOOSPERMIA 23 0.0599
45 PARASITIC GASTROENTERITIS 11 0.0576
46 CHONDROSARCOMA 9 0.0570
47 CELLULITIS GANGRENOUS 11 0.0558
48 SARS-COV-2 TEST NEGATIVE 36 0.0533
49 SUBDURAL HYGROMA 16 0.0526
50 CHROMOSOME ANALYSIS ABNORMAL 13 0.0512
51 METASTASES TO MUSCLE 9 0.0497
52 HIGH-GRADE B-CELL LYMPHOMA 9 0.0481
53 MARGINAL ZONE LYMPHOMA 10 0.0467
54 HEPATOSPLENIC T-CELL LYMPHOMA 17 0.0458
55 CYTOPENIA 557 0.0454
56 GRANULOCYTES ABNORMAL 9 0.0448
57 ANGIOCENTRIC LYMPHOMA 22 0.0447
58 METASTASES TO SPLEEN 18 0.0436
59 APLASIA 85 0.0434
60 SOFT TISSUE SARCOMA 15 0.0430
61 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 28 0.0427
62 METASTASES TO BREAST 14 0.0422
63 DIFFUSE LARGE B-CELL LYMPHOMA 325 0.0421
64 NEUROBLASTOMA 16 0.0418
65 FEBRILE NEUTROPENIA 2741 0.0413
66 MYELODYSPLASTIC SYNDROME 553 0.0382
67 AUTOIMMUNE NEUTROPENIA 11 0.0381
68 TUMOUR COMPRESSION 12 0.0377
69 RENAL TUBULAR DISORDER 106 0.0376
70 ENCEPHALITIS CYTOMEGALOVIRUS 16 0.0365
71 HAEMATOTOXICITY 346 0.0364
72 PREMATURE MENOPAUSE 33 0.0357
73 ENTEROBACTER SEPSIS 13 0.0351
74 VULVOVAGINITIS 10 0.0340
75 ACUTE MYELOID LEUKAEMIA 524 0.0336
76 CENTRAL HYPOTHYROIDISM 11 0.0332
77 NEUTROPENIC SEPSIS 231 0.0323
78 METASTASES TO THE MEDIASTINUM 13 0.0316
79 FEBRILE BONE MARROW APLASIA 131 0.0308
80 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 9 0.0307
81 IDIOPATHIC PNEUMONIA SYNDROME 9 0.0302
82 VENA CAVA THROMBOSIS 50 0.0301
83 METASTASES TO HEART 9 0.0298
84 FANCONI SYNDROME ACQUIRED 52 0.0296
85 CYSTITIS HAEMORRHAGIC 116 0.0287
86 MUCOSAL INFLAMMATION 748 0.0285
87 SKIN TURGOR DECREASED 11 0.0284
88 CENTRAL NERVOUS SYSTEM LYMPHOMA 39 0.0283
89 ACQUIRED DIAPHRAGMATIC EVENTRATION 10 0.0282
90 PLASMABLASTIC LYMPHOMA 10 0.0279
91 RECALL PHENOMENON 23 0.0275
92 NEUTROPENIC INFECTION 26 0.0272
93 SECOND PRIMARY MALIGNANCY 224 0.0269
94 NEOPLASM RECURRENCE 91 0.0268
95 ACETABULUM FRACTURE 10 0.0267
96 KLEBSIELLA SEPSIS 30 0.0266
97 ENCEPHALOPATHY 638 0.0260
98 MANTLE CELL LYMPHOMA RECURRENT 11 0.0253
99 VENOOCCLUSIVE DISEASE 62 0.0247
100 ANGIODYSPLASIA 9 0.0247
101 PSEUDOMONAL BACTERAEMIA 21 0.0246
102 BONE MARROW TOXICITY 29 0.0245
103 DRUG CLEARANCE DECREASED 31 0.0237
104 DYSPLASIA 28 0.0233
105 KLEBSIELLA BACTERAEMIA 22 0.0232
106 RENAL TUBULAR DYSFUNCTION 13 0.0230
107 NEPHROGENIC DIABETES INSIPIDUS 26 0.0225
108 TUMOUR LYSIS SYNDROME 196 0.0223
109 CAECITIS 10 0.0222
110 OTOTOXICITY 41 0.0222
111 METASTASES TO BONE MARROW 11 0.0220
112 BODY HEIGHT BELOW NORMAL 14 0.0218
113 GENE MUTATION 43 0.0217
114 BONE MARROW FAILURE 436 0.0214
115 HUMAN HERPESVIRUS 8 INFECTION 13 0.0213
116 SARCOMA 24 0.0212
117 MOTOR DEVELOPMENTAL DELAY 12 0.0208
118 SYSTEMIC CANDIDA 52 0.0207
119 RENAL TUBULAR INJURY 25 0.0206
120 PERIORBITAL CELLULITIS 11 0.0205
121 TOXIC ENCEPHALOPATHY 103 0.0203
122 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 12 0.0203
123 NEUROTOXICITY 348 0.0198
124 TRACHEITIS 15 0.0197
125 VIRAL HAEMORRHAGIC CYSTITIS 14 0.0197
126 ABDOMINAL LYMPHADENOPATHY 17 0.0196
127 ANGIOSARCOMA 9 0.0195
128 ACUTE PROMYELOCYTIC LEUKAEMIA 20 0.0195
129 VASOGENIC CEREBRAL OEDEMA 14 0.0194
130 EAR MALFORMATION 9 0.0194
131 OVARIAN DISORDER 18 0.0191
132 ESCHERICHIA BACTERAEMIA 45 0.0191
133 ARACHNOIDITIS 13 0.0188
134 THERAPY PARTIAL RESPONDER 291 0.0186
135 KLEBSIELLA TEST POSITIVE 12 0.0184
136 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 9 0.0183
137 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 107 0.0180
138 OLIGOHYDRAMNIOS 60 0.0180
139 VENOOCCLUSIVE LIVER DISEASE 87 0.0176
140 DISEASE PROGRESSION 2084 0.0176
141 HEPATITIS E 27 0.0171
142 GRAFT COMPLICATION 10 0.0170
143 CYTOKINE RELEASE SYNDROME 341 0.0170
144 QUADRIPLEGIA 35 0.0170
145 ACUTE LYMPHOCYTIC LEUKAEMIA 48 0.0169
146 ENGRAFTMENT SYNDROME 10 0.0169
147 TRACHEOBRONCHITIS 13 0.0169
148 MYELOPATHY 32 0.0168
149 NEPHROPATHY TOXIC 189 0.0168
150 CARDIOTOXICITY 149 0.0167
151 SUPERFICIAL VEIN THROMBOSIS 14 0.0166
152 NEUTROPENIC COLITIS 34 0.0164
153 STEM CELL TRANSPLANT 41 0.0164
154 PNEUMOTHORAX SPONTANEOUS 11 0.0162
155 MYELOSUPPRESSION 579 0.0161
156 EPSTEIN-BARR VIRUS TEST POSITIVE 10 0.0158
157 METASTASES TO PERITONEUM 40 0.0158
158 SCEDOSPORIUM INFECTION 11 0.0156
159 PLATELET TRANSFUSION 20 0.0155
160 GASTROINTESTINAL TOXICITY 74 0.0154
161 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 11 0.0153
162 LEUKOENCEPHALOPATHY 56 0.0150
163 PSEUDOMONAL SEPSIS 26 0.0148
164 HEPATITIS B REACTIVATION 47 0.0148
165 BLOOD LACTATE DEHYDROGENASE ABNORMAL 10 0.0147
166 STREPTOCOCCAL BACTERAEMIA 16 0.0147
167 PANCYTOPENIA 816 0.0146
168 SYSTEMIC MYCOSIS 17 0.0146
169 BLOOD LACTATE DEHYDROGENASE INCREASED 226 0.0142
170 METASTASES TO MENINGES 32 0.0141
171 NEUTROPENIA 1910 0.0140
172 THROMBOCYTOPENIA 1570 0.0140
173 HYPOGAMMAGLOBULINAEMIA 91 0.0138
174 CYTOMEGALOVIRUS CHORIORETINITIS 27 0.0138
175 INTUSSUSCEPTION 13 0.0136
176 ENTEROCUTANEOUS FISTULA 12 0.0136
177 RESORPTION BONE INCREASED 11 0.0134
178 GASTRITIS HAEMORRHAGIC 20 0.0134
179 POST-ACUTE COVID-19 SYNDROME 16 0.0129
180 PERIPHERAL MOTOR NEUROPATHY 18 0.0128
181 PERIPHERAL NERVE INJURY 11 0.0126
182 PYELOCALIECTASIS 12 0.0125
183 POSTICTAL STATE 13 0.0125
184 JC VIRUS INFECTION 20 0.0125
185 FOETAL GROWTH RESTRICTION 76 0.0125
186 SEPSIS NEONATAL 10 0.0123
187 BLOOD FIBRINOGEN DECREASED 14 0.0123
188 METASTASES TO LUNG 139 0.0120
189 DILATED CARDIOMYOPATHY 12 0.0119
190 BK VIRUS INFECTION 40 0.0118
191 B-CELL LYMPHOMA 40 0.0118
192 HEPATOSPLENOMEGALY 30 0.0117
193 HYPOPHOSPHATAEMIA 85 0.0115
194 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 109 0.0114
195 TUMOUR NECROSIS 12 0.0114
196 PNEUMONIA CYTOMEGALOVIRAL 22 0.0113
197 HYPERLEUKOCYTOSIS 10 0.0113
198 CANDIDA SEPSIS 10 0.0111
199 PNEUMONIA FUNGAL 44 0.0111
200 MYELITIS 17 0.0110
201 DEVELOPMENTAL HIP DYSPLASIA 9 0.0108
202 ADENOCARCINOMA GASTRIC 10 0.0108
203 NEOPLASM PROGRESSION 368 0.0106
204 HYPOALBUMINAEMIA 80 0.0103
205 BONE MARROW DEPRESSION 10 0.0102
206 FUNGAEMIA 16 0.0102
207 TUMOUR HAEMORRHAGE 29 0.0102
208 ENTEROCOCCAL INFECTION 49 0.0101
209 BACTERIAL SEPSIS 33 0.0101
210 HYPOFIBRINOGENAEMIA 10 0.0101
211 KLEBSIELLA INFECTION 51 0.0101
212 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 83 0.0101
213 PNEUMOCYSTIS JIROVECII INFECTION 12 0.0100
214 DIABETES INSIPIDUS 24 0.0100
215 OROPHARYNGEAL CANDIDIASIS 9 0.0099
216 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 14 0.0099
217 MENINGITIS BACTERIAL 14 0.0098
218 HISTIOCYTOSIS HAEMATOPHAGIC 29 0.0098
219 CYTOGENETIC ABNORMALITY 11 0.0097
220 DEMYELINATING POLYNEUROPATHY 10 0.0097
221 LEUKOPENIA 486 0.0097
222 NOROVIRUS INFECTION 14 0.0097
223 BLOOD CULTURE POSITIVE 29 0.0097
224 RENAL TUBULAR ACIDOSIS 21 0.0096
225 DIFFUSE ALVEOLAR DAMAGE 11 0.0096
226 ENTEROBACTER INFECTION 16 0.0095
227 POSTOPERATIVE WOUND COMPLICATION 12 0.0094
228 ABDOMINAL MASS 25 0.0093
229 STRONGYLOIDIASIS 15 0.0093
230 PERIPHERAL SENSORY NEUROPATHY 54 0.0092
231 HEARING IMPAIRED 55 0.0092
232 BRONCHOPULMONARY ASPERGILLOSIS 71 0.0091
233 PNEUMONIA PSEUDOMONAL 14 0.0091
234 BACTERAEMIA 108 0.0091
235 PACKED RED BLOOD CELL TRANSFUSION 12 0.0091
236 SYSTEMIC INFECTION 15 0.0090
237 GLYCOSURIA 12 0.0089
238 LYMPHOMA 137 0.0089
239 POLYNEUROPATHY 105 0.0088
240 VARICELLA ZOSTER VIRUS INFECTION 18 0.0087
241 ADENOVIRUS INFECTION 25 0.0086
242 WHITE BLOOD CELL DISORDER 23 0.0086
243 PROCTALGIA 55 0.0085
244 METASTASIS 61 0.0085
245 PROCALCITONIN INCREASED 10 0.0085
246 MUCORMYCOSIS 22 0.0085
247 STREPTOCOCCAL SEPSIS 10 0.0084
248 RADIATION PNEUMONITIS 18 0.0084
249 SEPTIC SHOCK 365 0.0084
250 OSTEOLYSIS 17 0.0083
251 ENTEROCOLITIS 47 0.0081
252 LYMPHOPENIA 115 0.0081
253 FOETAL DEATH 42 0.0081
254 GRANULOCYTE COUNT DECREASED 15 0.0081
255 OESOPHAGEAL CANDIDIASIS 32 0.0080
256 MENINGITIS CRYPTOCOCCAL 14 0.0080
257 PLATELET COUNT ABNORMAL 48 0.0079
258 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 40 0.0079
259 OSTEOPOROTIC FRACTURE 15 0.0078
260 HYPERBILIRUBINAEMIA 81 0.0078
261 GLOMERULONEPHRITIS 19 0.0078
262 MULTIPLE-DRUG RESISTANCE 24 0.0077
263 CYTOMEGALOVIRUS INFECTION REACTIVATION 34 0.0077
264 PNEUMONIA KLEBSIELLA 14 0.0076
265 LUNG OPACITY 20 0.0076
266 METASTASES TO LYMPH NODES 51 0.0075
267 PAPILLARY THYROID CANCER 13 0.0075
268 NEUTROPHIL COUNT ABNORMAL 21 0.0074
269 PNEUMONIA PNEUMOCOCCAL 11 0.0074
270 ENCEPHALITIS VIRAL 9 0.0074
271 RECURRENT CANCER 30 0.0073
272 SEPSIS 819 0.0073
273 HAEMOGLOBIN ABNORMAL 47 0.0073
274 BLOOD ELECTROLYTES ABNORMAL 9 0.0073
275 ESCHERICHIA SEPSIS 21 0.0072
276 GRAFT VERSUS HOST DISEASE 52 0.0072
277 HYDRONEPHROSIS 54 0.0072
278 WHITE BLOOD CELL COUNT ABNORMAL 46 0.0072
279 MALIGNANT NEOPLASM PROGRESSION 734 0.0072
280 CYTOMEGALOVIRUS INFECTION 119 0.0072
281 CUTANEOUS T-CELL LYMPHOMA 9 0.0071
282 OSTEOMALACIA 11 0.0071
283 EROSIVE OESOPHAGITIS 12 0.0071
284 HERPES SIMPLEX 46 0.0071
285 IMMUNE THROMBOCYTOPENIC PURPURA 20 0.0071
286 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 15 0.0070
287 LYMPHOCYTOSIS 15 0.0070
288 DEVICE RELATED SEPSIS 14 0.0069
289 BLADDER SPASM 13 0.0069
290 SMALL INTESTINAL PERFORATION 13 0.0069
291 KIDNEY FIBROSIS 12 0.0069
292 DISEASE RECURRENCE 329 0.0069
293 STAPHYLOCOCCAL BACTERAEMIA 30 0.0069
294 NON-HODGKIN'S LYMPHOMA 9 0.0069
295 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 19 0.0069
296 ELECTROLYTE IMBALANCE 79 0.0068
297 CLOSTRIDIAL INFECTION 23 0.0068
298 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 12 0.0068
299 ANAEMIA 1274 0.0067
300 BONE MARROW DISORDER 20 0.0066
301 CLOSTRIDIUM DIFFICILE COLITIS 70 0.0066
302 PARAINFLUENZAE VIRUS INFECTION 10 0.0066
303 CARDIOMYOPATHY 97 0.0066
304 SOFT TISSUE INFECTION 12 0.0066
305 PSEUDOMONAS INFECTION 56 0.0065
306 MALIGNANT PLEURAL EFFUSION 11 0.0065
307 PULMONARY TOXICITY 46 0.0065
308 HEPATOTOXICITY 143 0.0064
309 TUBULOINTERSTITIAL NEPHRITIS 119 0.0063
310 HYPERTRIGLYCERIDAEMIA 37 0.0063
311 ALOPECIA AREATA 11 0.0063
312 MULTIPLE ORGAN DYSFUNCTION SYNDROME 177 0.0062
313 HEPATIC LESION 27 0.0062
314 CACHEXIA 32 0.0062
315 SUSPECTED OFF LABEL USE 28 0.0062
316 HEPATITIS B 37 0.0061
317 AGRANULOCYTOSIS 114 0.0061
318 NEUROLOGICAL DECOMPENSATION 14 0.0060
319 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 16 0.0060
320 CONGESTIVE CARDIOMYOPATHY 25 0.0060
321 MANTLE CELL LYMPHOMA 9 0.0059
322 CARDIAC DYSFUNCTION 22 0.0059
323 ASPARTATE AMINOTRANSFERASE ABNORMAL 9 0.0059
324 ACUTE GRAFT VERSUS HOST DISEASE 27 0.0059
325 PARAPLEGIA 17 0.0059
326 METABOLIC DISORDER 34 0.0058
327 PARESIS 13 0.0058
328 ACUTE RESPIRATORY DISTRESS SYNDROME 103 0.0058
329 LEFT VENTRICULAR DYSFUNCTION 39 0.0058
330 LEFT VENTRICULAR FAILURE 20 0.0058
331 CAPILLARY LEAK SYNDROME 12 0.0058
332 PNEUMOTHORAX 92 0.0058
333 PNEUMOCYSTIS JIROVECII PNEUMONIA 58 0.0058
334 NEUTROPHIL COUNT DECREASED 235 0.0058
335 HYPERTRANSAMINASAEMIA 40 0.0057
336 LYMPHADENOPATHY MEDIASTINAL 11 0.0057
337 STAPHYLOCOCCUS TEST POSITIVE 12 0.0057
338 THERAPY NON-RESPONDER 255 0.0057
339 INFECTION 819 0.0057
340 AREFLEXIA 15 0.0056
341 BICYTOPENIA 11 0.0056
342 CLOSTRIDIUM DIFFICILE INFECTION 122 0.0056
343 DEVICE RELATED INFECTION 86 0.0056
344 SPEECH DISORDER DEVELOPMENTAL 16 0.0056
345 CHRONIC GRAFT VERSUS HOST DISEASE 20 0.0055
346 COVID-19 PNEUMONIA 65 0.0055
347 TETANY 10 0.0055
348 DEAFNESS NEUROSENSORY 18 0.0055
349 BODY TEMPERATURE ABNORMAL 10 0.0054
350 BRAIN HERNIATION 16 0.0054
351 METASTASES TO CENTRAL NERVOUS SYSTEM 69 0.0053
352 ESCHERICHIA INFECTION 44 0.0053
353 HEPATORENAL SYNDROME 9 0.0053
354 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 40 0.0053
355 CANDIDA INFECTION 89 0.0053
356 BLOOD DISORDER 42 0.0052
357 HYPERNATRAEMIA 26 0.0052
358 ALANINE AMINOTRANSFERASE ABNORMAL 11 0.0052
359 FOETAL DISTRESS SYNDROME 11 0.0052
360 HYPOPITUITARISM 9 0.0052
361 PYELONEPHRITIS ACUTE 10 0.0051
362 VASCULAR DEVICE INFECTION 23 0.0051
363 STAPHYLOCOCCAL SEPSIS 25 0.0051
364 HENOCH-SCHONLEIN PURPURA 11 0.0050
365 DRUG RESISTANCE 128 0.0050
366 APLASTIC ANAEMIA 26 0.0050
367 PANNICULITIS 12 0.0050
368 LYMPHADENITIS 12 0.0050
369 STOMATITIS 298 0.0049
370 PAPILLOEDEMA 22 0.0049
371 DIFFUSE ALOPECIA 9 0.0048
372 THROMBOTIC THROMBOCYTOPENIC PURPURA 17 0.0048
373 EMBOLISM 40 0.0048
374 SKIN TOXICITY 27 0.0048
375 METASTASES TO SPINE 16 0.0048
376 GROWTH RETARDATION 14 0.0048
377 GRANULOCYTOPENIA 27 0.0047
378 PULMONARY HAEMORRHAGE 37 0.0047
379 EJECTION FRACTION DECREASED 73 0.0047
380 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 12 0.0046
381 EPSTEIN-BARR VIRUS INFECTION 29 0.0046
382 METASTATIC NEOPLASM 20 0.0046
383 VENTRICULAR DYSFUNCTION 12 0.0046
384 AMYLASE INCREASED 17 0.0046
385 HYPOKALAEMIA 211 0.0046
386 PNEUMATOSIS INTESTINALIS 13 0.0046
387 CLOSTRIDIUM TEST POSITIVE 10 0.0045
388 ENTERITIS 29 0.0045
389 NEOPLASM 52 0.0045
390 MENINGITIS ASEPTIC 20 0.0045
391 WOUND DEHISCENCE 15 0.0044
392 ILEUS 54 0.0043
393 GUILLAIN-BARRE SYNDROME 21 0.0043
394 METABOLIC ENCEPHALOPATHY 13 0.0043
395 ASCITES 127 0.0043
396 HYPERCAPNIA 13 0.0043
397 NECROSIS 24 0.0043
398 BLOOD CREATINE INCREASED 19 0.0043
399 DILATATION VENTRICULAR 9 0.0043
400 CYTOMEGALOVIRUS VIRAEMIA 19 0.0043
401 DYSAESTHESIA 13 0.0042
402 FIBROSIS 13 0.0042
403 URINARY TRACT OBSTRUCTION 10 0.0042
404 CEREBELLAR SYNDROME 9 0.0041
405 MYCOBACTERIUM AVIUM COMPLEX INFECTION 11 0.0041
406 LYMPHOPROLIFERATIVE DISORDER 12 0.0041
407 RESPIRATORY ACIDOSIS 16 0.0041
408 STAPHYLOCOCCAL INFECTION 134 0.0041
409 PNEUMOCYSTIS JIROVECI PNEUMONIA 9 0.0040
410 ESCHERICHIA URINARY TRACT INFECTION 17 0.0040
411 NORMOCHROMIC NORMOCYTIC ANAEMIA 12 0.0040
412 CANDIDIASIS 16 0.0040
413 LYMPHADENOPATHY 141 0.0040
414 SMALL INTESTINAL OBSTRUCTION 49 0.0040
415 LUNG INFILTRATION 35 0.0040
416 ORAL CANDIDIASIS 52 0.0039
417 LUNG CONSOLIDATION 11 0.0039
418 UROSEPSIS 36 0.0039
419 THROMBOTIC MICROANGIOPATHY 38 0.0039
420 RESPIRATORY FAILURE 284 0.0039
421 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 9 0.0039
422 RHINOVIRUS INFECTION 15 0.0039
423 SPINAL CORD COMPRESSION 15 0.0038
424 COAGULOPATHY 64 0.0038
425 METASTASES TO LIVER 67 0.0038
426 ACIDOSIS 29 0.0038
427 ATRIAL FIBRILLATION 369 0.0038
428 GASTROINTESTINAL NECROSIS 11 0.0038
429 AZOTAEMIA 15 0.0038
430 CARDIAC FAILURE ACUTE 25 0.0037
431 BACTERIAL INFECTION 70 0.0037
432 STUPOR 12 0.0037
433 HYPOMAGNESAEMIA 52 0.0037
434 PLATELET COUNT DECREASED 395 0.0037
435 CEREBRAL ISCHAEMIA 19 0.0037
436 HAEMATOLOGICAL INFECTION 9 0.0037
437 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
438 SKIN NECROSIS 19 0.0037
439 SUBDURAL HAEMORRHAGE 10 0.0037
440 TRANSAMINASES INCREASED 81 0.0036
441 PRODUCT USE IN UNAPPROVED INDICATION 902 0.0036
442 RED CELL DISTRIBUTION WIDTH INCREASED 15 0.0036
443 MONOCYTE COUNT INCREASED 13 0.0036
444 HAEMODIALYSIS 30 0.0036
445 PLATELET DISORDER 9 0.0036
446 VENOUS THROMBOSIS 14 0.0036
447 HAEMORRHAGE 372 0.0036
448 ANAL ABSCESS 19 0.0035
449 ATELECTASIS 34 0.0035
450 MEAN CELL VOLUME INCREASED 9 0.0035
451 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 36 0.0035
452 AUTOIMMUNE HAEMOLYTIC ANAEMIA 12 0.0035
453 LEUKAEMIA 33 0.0035
454 DEAFNESS 91 0.0035
455 BLOOD CREATININE ABNORMAL 12 0.0035
456 VENTRICULAR HYPOKINESIA 11 0.0034
457 WHITE BLOOD CELL COUNT DECREASED 371 0.0034
458 PNEUMONITIS 93 0.0034
459 DISSEMINATED INTRAVASCULAR COAGULATION 48 0.0034
460 IMMUNOSUPPRESSION 30 0.0034
461 LYMPHOCYTE COUNT DECREASED 60 0.0034
462 LIVER ABSCESS 11 0.0034
463 MENTAL STATUS CHANGES 94 0.0034
464 FIBRIN D DIMER INCREASED 12 0.0034
465 CHRONIC LYMPHOCYTIC LEUKAEMIA 16 0.0034
466 HEPATIC FAILURE 101 0.0033
467 ATYPICAL PNEUMONIA 10 0.0033
468 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 183 0.0033
469 COLITIS 126 0.0033
470 MALNUTRITION 37 0.0033
471 MYELOFIBROSIS 10 0.0033
472 EMBOLISM VENOUS 10 0.0033
473 OESOPHAGITIS 36 0.0033
474 PREMATURE BABY 99 0.0033
475 ABSCESS LIMB 14 0.0033
476 BLOOD PHOSPHORUS DECREASED 12 0.0033
477 HYPOCALCAEMIA 62 0.0033
478 LOW BIRTH WEIGHT BABY 26 0.0033
479 PLEURAL EFFUSION 199 0.0033
480 ACCIDENT 39 0.0033
481 OFF LABEL USE 2840 0.0032
482 C-REACTIVE PROTEIN INCREASED 118 0.0032
483 BRAIN DEATH 10 0.0032
484 PYELONEPHRITIS 28 0.0032
485 ORGANISING PNEUMONIA 16 0.0032
486 SMALL FOR DATES BABY 16 0.0032
487 DIVERTICULUM INTESTINAL 14 0.0032
488 MYOCLONUS 38 0.0032
489 PREMATURE LABOUR 18 0.0032
490 ELECTROENCEPHALOGRAM ABNORMAL 10 0.0032
491 HYPERCALCAEMIA 39 0.0032
492 DRUG TOXICITY 43 0.0032
493 PNEUMONIA VIRAL 10 0.0031
494 NEUROPATHY PERIPHERAL 297 0.0031
495 NERVOUS SYSTEM DISORDER 97 0.0031
496 HAEMOTHORAX 9 0.0031
497 RENAL IMPAIRMENT 259 0.0031
498 HYPERPYREXIA 13 0.0031
499 MULTI-ORGAN FAILURE 53 0.0031
500 IMMUNE THROMBOCYTOPENIA 14 0.0031
501 ANGIOPATHY 17 0.0030
502 ACUTE KIDNEY INJURY 464 0.0030
503 INFLAMMATORY MARKER INCREASED 15 0.0030
504 HAEMORRHOIDS 59 0.0030
505 MIXED LIVER INJURY 9 0.0030
506 RESPIRATORY SYNCYTIAL VIRUS INFECTION 26 0.0030
507 NEUROLOGICAL SYMPTOM 17 0.0030
508 PYREXIA 1022 0.0030
509 CARDIAC TAMPONADE 14 0.0029
510 HEPATIC CYST 10 0.0029
511 PNEUMONIA BACTERIAL 27 0.0029
512 BODY TEMPERATURE INCREASED 60 0.0029
513 HYPERURICAEMIA 12 0.0029
514 CATHETER SITE INFECTION 11 0.0029
515 HAEMOLYTIC ANAEMIA 26 0.0029
516 OLIGURIA 18 0.0029
517 ALANINE AMINOTRANSFERASE INCREASED 178 0.0029
518 STILLBIRTH 14 0.0029
519 PROTEINURIA 55 0.0029
520 PREMATURE DELIVERY 46 0.0029
521 HYPERREFLEXIA 10 0.0029
522 BLOOD CREATININE INCREASED 187 0.0029
523 URINE OUTPUT DECREASED 25 0.0029
524 ACUTE HEPATIC FAILURE 39 0.0029
525 THROMBOPHLEBITIS 10 0.0028
526 CARDIOPULMONARY FAILURE 11 0.0028
527 LOCALISED OEDEMA 13 0.0028
528 PROSTATOMEGALY 11 0.0028
529 TACHYPNOEA 38 0.0028
530 HYPOPHAGIA 71 0.0028
531 MONOPLEGIA 12 0.0028
532 INTESTINAL PERFORATION 31 0.0028
533 THROMBOCYTOSIS 10 0.0027
534 GENERALISED TONIC-CLONIC SEIZURE 45 0.0027
535 HYPOVOLAEMIC SHOCK 13 0.0027
536 MYOSITIS 24 0.0027
537 RETINAL HAEMORRHAGE 19 0.0027
538 STATUS EPILEPTICUS 30 0.0027
539 RENAL TUBULAR NECROSIS 26 0.0026
540 LUNG INFECTION 41 0.0026
541 HYPERVOLAEMIA 13 0.0026
542 DERMATITIS BULLOUS 19 0.0026
543 DISEASE COMPLICATION 12 0.0026
544 ENCEPHALITIS 18 0.0026
545 CARDIAC FAILURE CHRONIC 11 0.0026
546 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 13 0.0026
547 TREATMENT FAILURE 211 0.0025
548 FACIAL PARESIS 9 0.0025
549 GASTRIC ULCER HAEMORRHAGE 14 0.0025
550 HEPATIC FUNCTION ABNORMAL 94 0.0025
551 PERICARDIAL EFFUSION 58 0.0025
552 HYPOXIA 88 0.0025
553 FAECAL INCONTINENCE 12 0.0025
554 HAEMODYNAMIC INSTABILITY 19 0.0025
555 PARTIAL SEIZURES 13 0.0025
556 SPLENOMEGALY 29 0.0025
557 SINUS TACHYCARDIA 35 0.0025
558 APPENDICITIS 23 0.0025
559 HAEMATURIA 84 0.0025
560 ACUTE RESPIRATORY FAILURE 47 0.0024
561 LEUKOCYTOSIS 44 0.0024
562 HERPES VIRUS INFECTION 14 0.0024
563 TOXICITY TO VARIOUS AGENTS 407 0.0024
564 CHEMOTHERAPY 9 0.0024
565 DISORIENTATION 94 0.0024
566 RENAL FUNCTION TEST ABNORMAL 11 0.0024
567 SUBARACHNOID HAEMORRHAGE 24 0.0024
568 MOUTH ULCERATION 49 0.0023
569 SARCOIDOSIS 11 0.0023
570 HAEMOGLOBIN DECREASED 236 0.0023
571 MITRAL VALVE INCOMPETENCE 26 0.0023
572 PERONEAL NERVE PALSY 13 0.0023
573 CATATONIA 12 0.0023
574 GRAND MAL CONVULSION 21 0.0023
575 PURPURA 20 0.0023
576 MENINGITIS 15 0.0022
577 ASPARTATE AMINOTRANSFERASE INCREASED 119 0.0022
578 SEROTONIN SYNDROME 43 0.0022
579 POSTOPERATIVE WOUND INFECTION 15 0.0022
580 URINARY TRACT DISORDER 10 0.0022
581 HYDROCEPHALUS 12 0.0022
582 RENAL FAILURE ACUTE 93 0.0022
583 FUNGAL INFECTION 73 0.0022
584 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 51 0.0022
585 ECCHYMOSIS 15 0.0022
586 GASTROINTESTINAL PERFORATION 9 0.0022
587 ARTHRITIS INFECTIVE 10 0.0022
588 PERFORMANCE STATUS DECREASED 10 0.0021
589 NEPHROPATHY 20 0.0021
590 METABOLIC ACIDOSIS 68 0.0021
591 ALTERED STATE OF CONSCIOUSNESS 46 0.0021
592 TONSILLITIS 11 0.0021
593 ATAXIA 25 0.0021
594 RENAL FAILURE 278 0.0021
595 SHOCK HAEMORRHAGIC 17 0.0021
596 LIPASE INCREASED 16 0.0021
597 VISUAL FIELD DEFECT 15 0.0021
598 NYSTAGMUS 11 0.0021
599 CIRCULATORY COLLAPSE 35 0.0021
600 ERYTHEMA MULTIFORME 19 0.0020
601 CARDIOGENIC SHOCK 29 0.0020
602 PETECHIAE 21 0.0020
603 METASTASES TO BONE 33 0.0020
604 HAEMORRHAGE INTRACRANIAL 30 0.0020
605 POISONING 25 0.0020
606 HEPATOCELLULAR INJURY 28 0.0020
607 PULMONARY ALVEOLAR HAEMORRHAGE 11 0.0020
608 RESPIRATORY DISTRESS 54 0.0020
609 HYPONATRAEMIA 110 0.0020
610 HEMIPARESIS 33 0.0019
611 CARDIAC FAILURE 156 0.0019
612 MASS 27 0.0019
613 BLOOD BILIRUBIN INCREASED 52 0.0019
614 TACHYCARDIA 171 0.0019
615 OSTEONECROSIS 63 0.0019
616 HYPOTONIA 19 0.0019
617 PULMONARY OEDEMA 85 0.0019
618 BLOOD ALBUMIN DECREASED 15 0.0019
619 ANURIA 16 0.0019
620 CHOLECYSTITIS 22 0.0018
621 DEEP VEIN THROMBOSIS 120 0.0018
622 ODYNOPHAGIA 11 0.0018
623 PRODUCT PRESCRIBING ISSUE 40 0.0018
624 THYROID CANCER 22 0.0018
625 BLOOD ALKALINE PHOSPHATASE INCREASED 45 0.0018
626 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 128 0.0018
627 SKIN MASS 12 0.0018
628 LIVE BIRTH 15 0.0018
629 PRODUCT USE ISSUE 334 0.0018
630 PATHOLOGICAL FRACTURE 9 0.0018
631 DERMATITIS 37 0.0018
632 ABSCESS 28 0.0018
633 BRAIN OEDEMA 22 0.0017
634 SHOCK 40 0.0017
635 WOUND INFECTION 19 0.0017
636 FAILURE TO THRIVE 9 0.0017
637 APHASIA 52 0.0017
638 INCOHERENT 11 0.0017
639 GENERALISED OEDEMA 21 0.0017
640 PULMONARY MASS 25 0.0017
641 IMMUNODEFICIENCY 25 0.0017
642 DRUG INTERACTION 264 0.0017
643 NEUTROPHIL COUNT INCREASED 17 0.0017
644 GASTROINTESTINAL INFLAMMATION 13 0.0017
645 HEPATIC CYTOLYSIS 21 0.0016
646 HEPATITIS 42 0.0016
647 RESPIRATORY DISORDER 49 0.0016
648 SKIN HYPERPIGMENTATION 14 0.0016
649 INTRACRANIAL PRESSURE INCREASED 9 0.0016
650 VOMITING 759 0.0016
651 CENTRAL NERVOUS SYSTEM LESION 22 0.0016
652 AMENORRHOEA 28 0.0016
653 ASPHYXIA 13 0.0016
654 HICCUPS 13 0.0016
655 TOXIC EPIDERMAL NECROLYSIS 24 0.0016
656 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35 0.0016
657 CHOLESTASIS 30 0.0016
658 C-REACTIVE PROTEIN ABNORMAL 10 0.0016
659 HYPERGLYCAEMIA 56 0.0015
660 TRANSFUSION 16 0.0015
661 CONFUSIONAL STATE 245 0.0015
662 CORONAVIRUS INFECTION 10 0.0015
663 CELLULITIS 76 0.0015
664 DELIRIUM 52 0.0015
665 HEPATITIS CHOLESTATIC 9 0.0015
666 BLOOD UREA INCREASED 25 0.0015
667 INGUINAL HERNIA 9 0.0015
668 NO THERAPEUTIC RESPONSE 18 0.0015
669 ORAL PAIN 33 0.0015
670 SUBDURAL HAEMATOMA 21 0.0015
671 INTERSTITIAL LUNG DISEASE 71 0.0015
672 THERAPEUTIC RESPONSE DECREASED 88 0.0014
673 INTENTIONAL PRODUCT USE ISSUE 127 0.0014
674 PNEUMONIA 469 0.0014
675 RENAL FAILURE CHRONIC 11 0.0014
676 BLOOD POTASSIUM DECREASED 43 0.0014
677 RIGHT VENTRICULAR FAILURE 10 0.0014
678 HEPATOMEGALY 14 0.0014
679 ADRENAL INSUFFICIENCY 17 0.0014
680 PARALYSIS 20 0.0014
681 RASH MACULO-PAPULAR 31 0.0014
682 DIARRHOEA HAEMORRHAGIC 13 0.0014
683 LIVER INJURY 34 0.0014
684 RENAL CYST 11 0.0014
685 URINARY INCONTINENCE 41 0.0014
686 ATRIAL FLUTTER 11 0.0014
687 CAESAREAN SECTION 16 0.0014
688 COVID-19 241 0.0014
689 DYSGRAPHIA 9 0.0014
690 EPISTAXIS 101 0.0013
691 MATERNAL EXPOSURE DURING PREGNANCY 120 0.0013
692 PULMONARY HYPERTENSION 28 0.0013
693 POLYURIA 11 0.0013
694 CEREBRAL HAEMORRHAGE 48 0.0013
695 DEVELOPMENTAL DELAY 12 0.0013
696 OPTIC NEURITIS 12 0.0013
697 OSTEOPENIA 20 0.0013
698 NEURALGIA 32 0.0013
699 SEIZURE 152 0.0013
700 TROPONIN INCREASED 10 0.0013
701 HYPERTHERMIA 10 0.0013
702 GASTROENTERITIS 19 0.0013
703 HAEMATEMESIS 33 0.0013
704 NERVE COMPRESSION 12 0.0013
705 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 38 0.0013
706 CHILLS 152 0.0013
707 TOXIC SKIN ERUPTION 13 0.0013
708 FULL BLOOD COUNT DECREASED 26 0.0013
709 HEPATIC ENCEPHALOPATHY 12 0.0013
710 MOTOR DYSFUNCTION 13 0.0013
711 INTESTINAL OBSTRUCTION 48 0.0013
712 DECREASED APPETITE 292 0.0013
713 HYPOTENSION 252 0.0013
714 DRUG INEFFECTIVE 1621 0.0012
715 PLATELET COUNT INCREASED 16 0.0012
716 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
717 MEDICAL DEVICE COMPLICATION 9 0.0012
718 NIGHT SWEATS 39 0.0012
719 PULMONARY EMBOLISM 115 0.0012
720 PHARYNGITIS 15 0.0012
721 PERITONITIS 25 0.0012
722 PANCREATITIS ACUTE 27 0.0012
723 DIALYSIS 17 0.0012
724 ATRIAL SEPTAL DEFECT 10 0.0012
725 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
726 GASTROINTESTINAL HAEMORRHAGE 99 0.0012
727 COMA 56 0.0012
728 ANAPHYLACTIC SHOCK 30 0.0012
729 CONGENITAL ANOMALY 9 0.0012
730 UNRESPONSIVE TO STIMULI 30 0.0012
731 HAEMATOCRIT DECREASED 23 0.0012
732 JAUNDICE 31 0.0012
733 END STAGE RENAL DISEASE 21 0.0012
734 EPILEPSY 35 0.0011
735 BONE PAIN 67 0.0011
736 SUDDEN DEATH 12 0.0011
737 HYPOTHYROIDISM 36 0.0011
738 DEHYDRATION 149 0.0011
739 DYSPHAGIA 106 0.0011
740 VASCULITIS 13 0.0011
741 PRESYNCOPE 27 0.0011
742 CARDIAC ARREST 91 0.0011
743 ASPIRATION 12 0.0011
744 DRUG LEVEL INCREASED 18 0.0011
745 DRUG-INDUCED LIVER INJURY 34 0.0011
746 DRUG INTOLERANCE 104 0.0011
747 ORAL HERPES 21 0.0011
748 RESPIRATORY TRACT INFECTION 28 0.0011
749 ABDOMINAL PAIN 248 0.0011
750 SKIN LESION 29 0.0011
751 CARDIOMEGALY 13 0.0011
752 ILL-DEFINED DISORDER 64 0.0011
753 CONVULSION 60 0.0010
754 FOLLICULITIS 11 0.0010
755 MYOCARDITIS 12 0.0010
756 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
757 BLOOD MAGNESIUM DECREASED 9 0.0010
758 HALLUCINATION, VISUAL 22 0.0010
759 HALLUCINATION 78 0.0010
760 GINGIVAL BLEEDING 14 0.0010
761 DECREASED ACTIVITY 11 0.0010
762 URINARY RETENTION 34 0.0010
763 RED BLOOD CELL COUNT DECREASED 29 0.0010
764 BLOOD SODIUM DECREASED 19 0.0010
765 GENERAL PHYSICAL HEALTH DETERIORATION 115 0.0010
766 GASTROINTESTINAL DISORDER 89 0.0010
767 DIARRHOEA 640 0.0010
768 COGNITIVE DISORDER 46 0.0010
769 DYSPNOEA EXERTIONAL 37 0.0010
770 SKIN INFECTION 11 0.0010
771 BLOOD CALCIUM DECREASED 11 0.0010
772 ANAPHYLACTIC REACTION 54 0.0010
773 SKIN ULCER 25 0.0010
774 DEPRESSED LEVEL OF CONSCIOUSNESS 38 0.0010
775 HERPES ZOSTER 55 0.0010
776 NAUSEA 753 0.0010
777 GASTRIC ULCER 18 0.0009
778 FULL BLOOD COUNT ABNORMAL 10 0.0009
779 AGITATION 69 0.0009
780 PULMONARY FIBROSIS 18 0.0009
781 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
782 BREAST PAIN 10 0.0009
783 TINNITUS 43 0.0009
784 MYDRIASIS 12 0.0009
785 DYSTONIA 18 0.0009
786 RENAL INJURY 27 0.0009
787 CONSTIPATION 198 0.0009
788 MUSCULOSKELETAL CHEST PAIN 14 0.0009
789 OBSTRUCTIVE AIRWAYS DISORDER 10 0.0009
790 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
791 EMPHYSEMA 9 0.0009
792 RHABDOMYOLYSIS 37 0.0009
793 OEDEMA 48 0.0009
794 PELVIC PAIN 16 0.0009
795 ULCER 14 0.0009
796 LIVER DISORDER 39 0.0009
797 INTERNATIONAL NORMALISED RATIO INCREASED 25 0.0009
798 SENSORY DISTURBANCE 14 0.0009
799 INCONTINENCE 9 0.0009
800 PNEUMONIA ASPIRATION 21 0.0008
801 ISCHAEMIC STROKE 15 0.0008
802 GASTRITIS 22 0.0008
803 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
804 LIVER FUNCTION TEST ABNORMAL 24 0.0008
805 HAEMOPTYSIS 23 0.0008
806 FLUID OVERLOAD 12 0.0008
807 FOETAL EXPOSURE DURING PREGNANCY 67 0.0008
808 THROMBOSIS 66 0.0008
809 CHRONIC KIDNEY DISEASE 62 0.0008
810 DYSURIA 30 0.0008
811 INFLAMMATION 42 0.0008
812 EATING DISORDER 17 0.0008
813 SYNCOPE 79 0.0008
814 ANOREXIA 10 0.0008
815 EXPOSURE DURING PREGNANCY 48 0.0008
816 FACE OEDEMA 13 0.0008
817 LETHARGY 44 0.0008
818 CYANOSIS 12 0.0008
819 ARRHYTHMIA 36 0.0008
820 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
821 CYSTITIS 24 0.0008
822 VIRAL INFECTION 25 0.0008
823 NEOPLASM MALIGNANT 50 0.0007
824 DRUG EFFECT INCOMPLETE 27 0.0007
825 LACTIC ACIDOSIS 24 0.0007
826 PANCREATITIS 39 0.0007
827 RENAL DISORDER 34 0.0007
828 PSYCHOTIC DISORDER 21 0.0007
829 DELUSION 11 0.0007
830 ASTHENIA 264 0.0007
831 MENTAL IMPAIRMENT 17 0.0007
832 WEIGHT DECREASED 195 0.0007
833 ELECTROCARDIOGRAM QT PROLONGED 25 0.0007
834 INFUSION RELATED REACTION 46 0.0007
835 MELAENA 15 0.0007
836 LUNG DISORDER 33 0.0007
837 DEATH 573 0.0007
838 DYSKINESIA 27 0.0007
839 OSTEOMYELITIS 12 0.0007
840 HEPATIC ENZYME INCREASED 45 0.0007
841 ALOPECIA 128 0.0007
842 DRUG EXPOSURE DURING PREGNANCY 22 0.0006
843 FEEDING DISORDER 13 0.0006
844 ABDOMINAL PAIN LOWER 16 0.0006
845 STEVENS-JOHNSON SYNDROME 14 0.0006
846 CONDITION AGGRAVATED 190 0.0006
847 DIPLOPIA 16 0.0006
848 VENTRICULAR TACHYCARDIA 10 0.0006
849 BONE DISORDER 11 0.0006
850 OEDEMA PERIPHERAL 73 0.0006
851 BLOOD COUNT ABNORMAL 9 0.0006
852 CONJUNCTIVITIS 11 0.0006
853 MOVEMENT DISORDER 19 0.0006
854 PALLOR 16 0.0006
855 OSTEOPOROSIS 24 0.0006
856 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
857 ACUTE MYOCARDIAL INFARCTION 17 0.0006
858 SOMNOLENCE 116 0.0006
859 CEREBRAL INFARCTION 14 0.0006
860 POST PROCEDURAL COMPLICATION 11 0.0006
861 LOSS OF CONSCIOUSNESS 73 0.0006
862 BLINDNESS 23 0.0006
863 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
864 BRADYCARDIA 29 0.0005
865 RASH ERYTHEMATOUS 26 0.0005
866 DISTURBANCE IN ATTENTION 29 0.0005
867 OXYGEN SATURATION DECREASED 30 0.0005
868 HYPERKALAEMIA 18 0.0005
869 COLD SWEAT 9 0.0005
870 ABNORMAL BEHAVIOUR 20 0.0005
871 PRODUCTIVE COUGH 24 0.0005
872 PREGNANCY 10 0.0005
873 CHOLELITHIASIS 16 0.0005
874 EXTRAPYRAMIDAL DISORDER 12 0.0005
875 BACK PAIN 112 0.0005
876 HYPERTENSION 102 0.0005
877 DYSPNOEA 271 0.0005
878 ERYTHEMA 98 0.0005
879 ADVERSE EVENT 43 0.0005
880 OROPHARYNGEAL PAIN 42 0.0005
881 CHEST PAIN 84 0.0005
882 NO ADVERSE EVENT 81 0.0004
883 MUSCLE TWITCHING 10 0.0004
884 HYPOGLYCAEMIA 21 0.0004
885 CARDIO-RESPIRATORY ARREST 18 0.0004
886 FATIGUE 334 0.0004
887 BLISTER 24 0.0004
888 CARDIAC DISORDER 38 0.0004
889 SPEECH DISORDER 21 0.0004
890 COUGH 112 0.0004
891 CHROMATURIA 9 0.0004
892 URINARY TRACT INFECTION 67 0.0004
893 BLOOD PRESSURE DECREASED 26 0.0004
894 CHEST DISCOMFORT 40 0.0004
895 ERECTILE DYSFUNCTION 10 0.0004
896 PARAESTHESIA 59 0.0004
897 DYSARTHRIA 14 0.0004
898 VAGINAL HAEMORRHAGE 16 0.0004
899 IMPAIRED HEALING 12 0.0004
900 ABDOMINAL DISTENSION 38 0.0004
901 DIVERTICULITIS 10 0.0004
902 POLLAKIURIA 15 0.0004
903 RASH 156 0.0004
904 RESTLESSNESS 13 0.0004
905 SKIN DISORDER 11 0.0003
906 RECTAL HAEMORRHAGE 14 0.0003
907 PAIN 200 0.0003
908 GYNAECOMASTIA 10 0.0003
909 FEMUR FRACTURE 10 0.0003
910 MOBILITY DECREASED 23 0.0003
911 DYSPEPSIA 31 0.0003
912 PAIN IN EXTREMITY 92 0.0003
913 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
914 MUSCULAR WEAKNESS 35 0.0003
915 LABORATORY TEST ABNORMAL 9 0.0003
916 CARDIAC FAILURE CONGESTIVE 24 0.0003
917 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
918 TYPE 2 DIABETES MELLITUS 10 0.0003
919 TREMOR 49 0.0003
920 CEREBROVASCULAR ACCIDENT 50 0.0003
921 EMOTIONAL DISORDER 9 0.0003
922 DYSPHONIA 17 0.0003
923 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
924 HEADACHE 174 0.0003
925 MALAISE 120 0.0003
926 ECZEMA 14 0.0003
927 HYPERSENSITIVITY 49 0.0003
928 HEART RATE INCREASED 26 0.0003
929 DISCOMFORT 16 0.0003
930 AGGRESSION 13 0.0003
931 TREATMENT NONCOMPLIANCE 14 0.0003
932 FLUID RETENTION 13 0.0003
933 HYPOAESTHESIA 38 0.0003
934 ACCIDENTAL OVERDOSE 9 0.0002
935 SWELLING 23 0.0002
936 PROSTATE CANCER 19 0.0002
937 ARTHROPATHY 13 0.0002
938 MIGRAINE 22 0.0002
939 DIZZINESS 110 0.0002
940 HAEMATOCHEZIA 12 0.0002
941 AMNESIA 14 0.0002
942 SINUSITIS 22 0.0002
943 GAIT DISTURBANCE 41 0.0002
944 MYALGIA 36 0.0002
945 MEMORY IMPAIRMENT 29 0.0002
946 HYPOACUSIS 9 0.0002
947 MENTAL DISORDER 9 0.0002
948 ARTHRALGIA 85 0.0002
949 HYPERHIDROSIS 26 0.0002
950 PRURITUS 77 0.0002
951 IRRITABILITY 12 0.0002
952 UNEVALUABLE EVENT 15 0.0002
953 DEPRESSION 42 0.0002
954 SKIN EXFOLIATION 15 0.0002
955 BLOOD GLUCOSE INCREASED 33 0.0002
956 MUSCULOSKELETAL PAIN 9 0.0002
957 RHINORRHOEA 11 0.0002
958 BLOOD PRESSURE INCREASED 26 0.0002
959 OVERDOSE 36 0.0002
960 ANXIETY 47 0.0002
961 DYSGEUSIA 12 0.0002
962 MYOCARDIAL INFARCTION 28 0.0002
963 PERIPHERAL SWELLING 24 0.0002
964 VISUAL IMPAIRMENT 19 0.0002
965 INFLUENZA 17 0.0002
966 ABDOMINAL PAIN UPPER 31 0.0002
967 VISION BLURRED 19 0.0001
968 ADVERSE DRUG REACTION 12 0.0001
969 FALL 43 0.0001
970 FLUSHING 13 0.0001
971 FEELING ABNORMAL 29 0.0001
972 DIABETES MELLITUS 9 0.0001
973 WEIGHT INCREASED 26 0.0001
974 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
975 ABDOMINAL DISCOMFORT 18 0.0001
976 MUSCLE SPASMS 19 0.0001
977 PALPITATIONS 12 0.0001
978 URTICARIA 16 0.0001
979 HOSPITALISATION 13 0.0001
980 ASTHMA 9 0.0001
981 DRY SKIN 10 0.0001
982 NASOPHARYNGITIS 11 0.0001
983 DRUG DEPENDENCE 9 0.0001
984 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
985 INSOMNIA 13 0.0000